We are live on ! Find out more
LLY icon

Eli Lilly

4,408 hedge funds and large institutions have $713B invested in Eli Lilly in 2026 Q1 according to their latest regulatory filings, with 243 funds opening new positions, 1,964 increasing their positions, 1,709 reducing their positions, and 231 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more capital inflows, than outflows

Capital inflows: $109B | Capital outflows: $33.5B

15% more repeat investments, than reductions

Existing positions increased: 1,964 | Existing positions reduced: 1,709

5% more first-time investments, than exits

New positions opened: 243 | Existing positions closed: 231

0.93% less ownership

Funds ownership: 83.03% → 82.11% (-0.93%)

1% less funds holding

Funds holding: 4,466 → 4,408 (-58)

22% less funds holding in top 10

Funds holding in top 10: 491 → 382 (-109)

29% less call options, than puts

Call options by funds: $9.5B | Put options by funds: $13.4B

Holders
4,408
Holders Change
-58
Holders Change %
-1.3%
% of All Funds
53.47%
Holding in Top 10
382
Holding in Top 10 Change
-109
Holding in Top 10 Change %
-22.2%
% of All Funds
4.63%
New
243
Increased
1,964
Reduced
1,709
Closed
231
Calls
$9.5​B
Puts
$13.4​B
Net Calls
-⁠$3.91​B
Net Calls Change
-⁠$4.47​B

LLY Hedge Fund Activity: Q1 2026 in Review

4,408 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2026, worth a combined $713B — down 15% from $843B a quarter earlier.

Buyers outnumbered sellers: 243 funds opened new LLY positions and 231 closed out — a net gain of 12 holders — while 1,964 added to existing stakes and 1,709 trimmed.

The largest buyer was Fifth Third Bancorp, adding an estimated $1.52B. The largest seller was Capital International Investors, cutting an estimated $3.8B.

  • 4,408 institutional investors held Eli Lilly (LLY) as of Q1 2026, down from 4,466 in Q4 2025.
  • Funds reported $713B of Eli Lilly stock for Q1 2026, down 15% quarter-over-quarter.
  • 243 funds opened new Eli Lilly positions in Q1 2026 and 231 closed out, a net change of +12 holders.
  • The largest Eli Lilly buyer in Q1 2026 was Fifth Third Bancorp, an estimated $1.52B added.
  • The largest Eli Lilly seller in Q1 2026 was Capital International Investors, an estimated $3.8B sold.

Based on aggregated 13F filings for Q1 2026.